prazosin has been researched along with Menopause in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Excerpt | Relevance | Reference |
---|---|---|
" during different phases of the menstrual cycle, in postmenopausal women, term pregnancy, and during depo-progestin (medroxyprogesterone acetate) therapy." | 3.66 | Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium. ( Bottari, SP; Kaivez, E; Lescrainier, JP; Vauquelin, GP; Vokaer, A, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bottari, SP | 1 |
Vokaer, A | 1 |
Kaivez, E | 1 |
Lescrainier, JP | 1 |
Vauquelin, GP | 1 |
1 other study available for prazosin and Menopause
Article | Year |
---|---|
Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium.
Topics: Binding, Competitive; Estradiol; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone | 1983 |